跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 28,540 条关于
“immune-mediated conditions”
全部
28,540
临床试验
13,128
药物
630
机构
136
资讯
14,646
去年
Novartis and Monte Rosa Therapeutics Partner to Advance VAV1 Degrader for Immune-Mediated Conditions
去年
Monte Rosa and Novartis Partner to Develop VAV1 Molecular Glue Degraders in $2.1B Deal
2年前
EMA Approves First Ustekinumab Biosimilar, Uzpruvo, for Inflammatory Conditions
去年
VYNE Therapeutics Advances VYN201 and VYN202 in Vitiligo and Psoriasis Trials
去年
Monte Rosa and Novartis Partner to Advance VAV1 Molecular Glue Degrader MRT-6160
5个月前
Novartis Acquires Excellergy for Up to $2 Billion to Strengthen Immunology Portfolio
去年
Novartis and Monte Rosa Therapeutics Partner to Advance VAV1 Molecular Glue Degrader
去年
Sudo Biosciences Initiates Phase I Trial of Brain-Penetrant TYK2 Inhibitor SUDO-550 for Neuroinflammation
3个月前
Amivantamab Shows Preclinical Immune-Mediated Activity in Mesothelioma Through Dual EGFR/MET Targeting
3个月前
Difficult-to-Treat Immune-Mediated Inflammatory Diseases Demand Holistic Strategy Beyond Drug Switching
第 1 页，共 1465 页
上一页
下一页
